These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24858381)

  • 21. Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin.
    Dube D; Khatri K; Goyal AK; Mishra N; Vyas SP
    Drug Dev Ind Pharm; 2010 May; 36(5):547-55. PubMed ID: 19895190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro Release and Bioavailability of Silybin from Micelle-Templated Porous Calcium Phosphate Microparticles.
    Zhu Y; Wang M; Zhang Y; Zeng J; Omari-Siaw E; Yu J; Xu X
    AAPS PharmSciTech; 2016 Oct; 17(5):1232-9. PubMed ID: 26669888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A promising drug controlled-release system based on diacetylene/phospholipid polymerized vesicles.
    Guo C; Liu S; Jiang C; Li W; Dai Z; Fritz H; Wu X
    Langmuir; 2009 Nov; 25(22):13114-9. PubMed ID: 19852472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new method for liposome preparation using a membrane contactor.
    Jaafar-Maalej C; Charcosset C; Fessi H
    J Liposome Res; 2011 Sep; 21(3):213-20. PubMed ID: 20860451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in the nanotechnology-based drug delivery of Silybin.
    Wang Y; Zhang L; Wang Q; Zhang D
    J Biomed Nanotechnol; 2014 Apr; 10(4):543-58. PubMed ID: 24734507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on the preparation and bio-distribution of silybin lipid nanospheres].
    Xu XM; Li Q; Zhu Y; Shen S; Shen Z; Yu JN
    Zhongguo Zhong Yao Za Zhi; 2005 Dec; 30(24):1912-4. PubMed ID: 16494021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting microencapsulation of drugs in liposomes.
    Kulkarni SB; Betageri GV; Singh M
    J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: In vitro study with finite and infinite dosage application.
    Chen M; Liu X; Fahr A
    Int J Pharm; 2011 Apr; 408(1-2):223-34. PubMed ID: 21316430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and performance evaluation of emulsomes as a drug delivery system for silybin.
    Zhou X; Chen Z
    Arch Pharm Res; 2015 Dec; 38(12):2193-200. PubMed ID: 26152876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and in vitro evaluation of povidone-sodium cholate-phospholipid mixed micelles for the solubilization of poorly soluble drugs.
    Zhu Y; Yu J; Tong S; Wang L; Peng M; Cao X; Xu X
    Arch Pharm Res; 2010 Jun; 33(6):911-7. PubMed ID: 20607496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidised derivatives of silybin and their antiradical and antioxidant activity.
    Gazák R; Svobodová A; Psotová J; Sedmera P; Prikrylová V; Walterová D; Kren V
    Bioorg Med Chem; 2004 Nov; 12(21):5677-87. PubMed ID: 15465345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of nanoscale multicompartment liposomes for combinatory drug delivery.
    Al-Jamal WT; Kostarelos K
    Int J Pharm; 2007 Mar; 331(2):182-5. PubMed ID: 17223294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-walled carbon nanotubes do not pierce aqueous phospholipid bilayers at low salt concentration.
    Shi L; Shi D; Nollert MU; Resasco DE; Striolo A
    J Phys Chem B; 2013 Jun; 117(22):6749-58. PubMed ID: 23659213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts.
    Kidd PM
    Altern Med Rev; 2009 Sep; 14(3):226-46. PubMed ID: 19803548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver Targeting Albumin-Coated Silybin-Phospholipid Particles Prepared by Nab™ Technology for Improving Treatment Effect of Acute Liver Damage in Intravenous Administration.
    Lu C; Li X; Liang X; Zhang X; Yin T; Gou J; He H; Zhang Y; Tang X
    AAPS PharmSciTech; 2019 Aug; 20(7):293. PubMed ID: 31432294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained release of hydroxycamptothecin after subcutaneous administration using a novel phospholipid complex-DepoFoam technology.
    Zhao Y; Liu J; Sun X; Zhang ZR; Gong T
    Drug Dev Ind Pharm; 2010 Jul; 36(7):823-31. PubMed ID: 20515403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A New Type of Liquid Silymarin Proliposome Containing Bile Salts: Its Preparation and Improved Hepatoprotective Effects.
    Wang M; Xie T; Chang Z; Wang L; Xie X; Kou Y; Xu H; Gao X
    PLoS One; 2015; 10(12):e0143625. PubMed ID: 26674103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Size of thermosensitive liposomes influences content release.
    Hossann M; Wang T; Wiggenhorn M; Schmidt R; Zengerle A; Winter G; Eibl H; Peller M; Reiser M; Issels RD; Lindner LH
    J Control Release; 2010 Nov; 147(3):436-43. PubMed ID: 20727921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.